Advertisement
Advertisement

CDNA

CDNA logo

CareDx, Inc.

47.85
USD
Sponsored
+4.14
+9.47%
Aug 03, 15:59 UTC -4
Closed
exchange

After-Market

47.88

+0.03
+0.06%

CDNA Earnings Reports

Positive Surprise Ratio

CDNA beat 31 of 43 last estimates.

72%

Next Report

Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$113.71M
/
$0.19
Implied change from Q2 26 (Revenue/ EPS)
-13.82%
/
-48.65%
Implied change from Q3 25 (Revenue/ EPS)
+13.65%
/
-32.14%

CareDx, Inc. earnings per share and revenue

On Jul 30, 2026, CDNA reported earnings of 0.37 USD per share (EPS) for Q2 26, beating the estimate of 0.23 USD, resulting in a 55.79% surprise. Revenue reached 131.95 million, compared to an expected 116.33 million, with a 13.43% difference. The market reacted with a +14.72% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of 0.19 USD, with revenue projected to reach 113.71 million USD, implying an decrease of -48.65% EPS, and decrease of -13.82% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
BrightSpring Health Services, Inc. Common Stock
Report Date
Jul 31, 2026 For Q2 26
Estimate
$0.40
Actual
$0.45
Surprise
+11.22%
logo
Icon Plc
Report Date
Jul 29, 2026 For Q2 26
Estimate
$2.56
Actual
$2.56
Surprise
-0.20%
logo
Bausch + Lomb Corporation
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.15
Actual
$0.16
Surprise
+2.50%
logo
Avantor, Inc.
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.19
Actual
$0.21
Surprise
+8.58%
logo
Alignment Healthcare, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.13
Actual
$0.17
Surprise
+28.79%
logo
HCA Healthcare, Inc.
Report Date
Jul 24, 2026 For Q2 26
Estimate
$7.54
Actual
$7.62
Surprise
+1.03%
logo
Labcorp Holdings Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$4.92
Actual
$4.99
Surprise
+1.40%
logo
Medpace Holdings, Inc. Common Stock
Report Date
Jul 22, 2026 For Q2 26
Estimate
$4.05
Actual
$4.25
Surprise
+4.93%
logo
GeneDx Holdings Corp. Class A Common Stock
Report Date
Aug 03, 2026 For Q2 26
Estimate
-$0.18
Actual
$0.01
Surprise
+105.28%
logo
Teladoc Health, Inc.
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.25
Actual
-$0.21
Surprise
+17.61%
FAQ
For Q2 2026, CareDx, Inc. reported EPS of $0.37, beating estimates by 55.79%, and revenue of $131.95M, 13.43% above expectations.
The stock price moved up 14.72%, changed from $38.10 before the earnings release to $43.71 the day after.
The next earning report is scheduled for Nov 02, 2026.
Based on 11 analysts, CareDx, Inc. is expected to report EPS of $0.19 and revenue of $113.71M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement